Monitoring anticancer drugs.
D016907:Adverse Drug Reaction Reporting Systems; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011358:Product Surveillance, Postmarketing; D012306:Risk; D014481:United States
D000970:Antineoplastic Agents